Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2002
10/16/2002CN1374083A Cold resisting compound medicinal composition
10/16/2002CN1374082A Use of glycogen sulphofoenzyme inhibitor
10/16/2002CN1374081A Application of safrole oxide in the growth and death of vascular endothelial cell
10/16/2002CN1374080A Prepn and use of composition with cracked disulfide bond
10/16/2002CN1374079A Antiviral drug containing silverweed cinquefoil essence and its prepn
10/16/2002CN1374078A 外用组合物 Topical compositions
10/16/2002CN1374035A Process for producing one or more kinds of dry powder of carotenoid
10/16/2002CN1092663C Novel cephalosporin derivatives and processes for producing the same
10/16/2002CN1092658C Mesylate trihydrate salt of 5-(2-(4-(1,2-benziisothiazol-3-yl)-1-piperazinyl)ethyl)-6-chloro-1,3-dihydro-2-(1H)-indol-2-one
10/16/2002CN1092657C One pot synthesis of 2-oxazolidinone derivatives
10/16/2002CN1092656C Kinetic oxidaizoles
10/16/2002CN1092655C 哌啶衍生物 Piperidine derivatives
10/16/2002CN1092654C 4-phenylpiperidine compound
10/16/2002CN1092653C (4-piperidnyl)-1H-2-benzopyran derivatives used as antipsychotic agent
10/16/2002CN1092652C 2-imidazolinylaminoindole compound and composition containing the same use
10/16/2002CN1092649C Thiazolidinone compounds or angina pectoris curing or preventing agent with the same as active ingredient
10/16/2002CN1092647C New antiviral substituted pyrimidinedione homocarbocylic nucleoside derivatives and methods for preparation thereof and composition containing the same as active ingredients
10/16/2002CN1092645C Prevention/remedies for complication of diabetes
10/16/2002CN1092643C Certain aminomethyl phenylidazole derivatives, for intensifying memory
10/16/2002CN1092642C Quinoline derivatives as tachykinin NK 3 receptor antagonists
10/16/2002CN1092641C Preparation for medicine containing substituted pyridyl-dihydroxy-heptenonic acid or its salts
10/16/2002CN1092640C Imides as PDE III, PDE IV and TNF inhibitors
10/16/2002CN1092520C Ecological enema liquid for curing functional constipation
10/16/2002CN1092518C Gelding liquor for female livestocks
10/16/2002CN1092517C Method for lowering serum cholesterol levels with 2,6-dialkyl-4-silyl-phenols
10/16/2002CN1092516C Preparation for epidermis and process for preparing it
10/16/2002CN1092514C Photostable screening composition comprising dibenzoylmethane derivative and polysaccharide alkyl ether, and ue thereof
10/16/2002CA2406401A1 Process for preparation of sulfonamide derivatives and crystals thereof
10/16/2002CA2406198A1 Use of substituted 1-amino-5-phenylpentane-3-ol and/or 1-amino-6-phenylhexane-3-ol compounds as medicaments
10/16/2002CA2406161A1 2-guanidino-4-arylquinazolines as nhe-3 inhibitors
10/15/2002USRE37886 4-(1-(3,5bis(trifluoromethyl) benzoyl)-2-(phenylmethyl)-4-piperidinyl)-n-(2,6dimethylphenyl)-1-piperazine acetamide, having tachykinin and substance p antagonistic activity; analgesic and antiinflammatory agents
10/15/2002US6465687 Thyroid receptor ligands and method
10/15/2002US6465686 Halogenated 2-amino-5,6 heptenoic acid derivatives useful as nitric oxide synthase inhibitors
10/15/2002US6465663 Ethyl (e)-4-(2-(5,6-dihydro-5,5-dimethyl-naphthalen-8(7h)-one-2 -yl)ethenyl)benzoate and ethyl (e)-4-(2-(5,6-dihydro-5,5-dimethyl-8-(phenylthio)-naphthalenyl)ethenyl) benzoate
10/15/2002US6465660 Isoindoloindolone compounds
10/15/2002US6465647 Oxygen, sulfur and nitrogen substituted cyclohexene and cyclohexane derivatives having retinoid-like biological activity
10/15/2002US6465633 Compositions and methods of their use in the treatment, prevention and diagnosis of tuberculosis
10/15/2002US6465621 Polypeptides and polynucleotides of the gtp-binding protein family
10/15/2002US6465526 Natural mixture composed of higher primary aliphatic alcohols obtained from bee wax for the treatment of gastric and duodenal ulcers that also present antiinflamatory activity
10/15/2002US6465524 Therapy for obesity; psychological disorders
10/15/2002US6465522 Anthraquinone anticancer drugs
10/15/2002US6465521 Composition for desorbing bacteria
10/15/2002US6465519 Uses of modafinil and its D/L enantiomers
10/15/2002US6465518 2-amino-5-fluoro-6-(1-iminoethylamino)-hept-4-enoic acid, for example; treating or preventing various causes of inflammation
10/15/2002US6465517 Taurine, coenzyme q10 and additionally creatine, l-carnitine, certain vitamins and minerals, carbohydrates, proteins, fats and herbal extracts
10/15/2002US6465516 Increasing nitric oxide production by administering inhibitors of hmg-coa-reductase; treatment of diseases related to endothelial dysfunction
10/15/2002US6465515 Solid compositions suitable for oral administration containing non-hydroscopic salts of L-carnitine and alkanoyl L-carnitines
10/15/2002US6465514 Methods and compositions for the promotion of hair growth
10/15/2002US6465513 Multicyclic compounds which inhibit leukocyte adhesion mediated by VLA-4
10/15/2002US6465512 Leukemic cell growth inhibiting method
10/15/2002US6465511 Treatment of septic shock
10/15/2002US6465509 Pyrones as inhibitors of cyclooxygenase-2
10/15/2002US6465507 Antitumor agents
10/15/2002US6465506 Instillation techniques for ophthalmic agents to enhance treatment effect
10/15/2002US6465505 Benzyl-substituted benzimidazoles
10/15/2002US6465504 Such as 4-(3,5-bis(2-hydroxyphenyl)-(1,2,4)triazol-1-yl)-benzoic acid; treatment of iron overload by mobilizing and eliminating iron deposits; preventing organ damage, in particular of liver, heart and endocrine organs
10/15/2002US6465503 Selective urokinase inhibitors
10/15/2002US6465502 Additional therapeutic use
10/15/2002US6465500 Indole derivatives as 5-HT1 agonists
10/15/2002US6465497 Arylthiazolidinedione derivatives
10/15/2002US6465496 Dupont form 2 ethanol and isopropanol adducts; suspending torsemide in water, basifying, adding organic solvent, acid precipitating and isolating adduct
10/15/2002US6465495 Preparation of pyridone-based phosphotyrosine mimetics and uses thereof
10/15/2002US6465494 Methods for treatment of cystic fibrosis
10/15/2002US6465493 Such as 4-(4-(4-fluorophenyl)-5-(2-pyridyl)-1-hydroxy-1h-imidazol-2-yl)benzonitrile; alk5 mediated diseases such as arthritis, osteoporosis, kidney and renal diseases, conges-tive heart failure, ulcers, diabetic nephropathy
10/15/2002US6465492 Heterocyclic compounds
10/15/2002US6465491 6-phenylpyridyl-2-amine derivatives
10/15/2002US6465490 Sulfuric acid mono-[3({1-[2-(4-fluoro-phenyl)-ethyl]-piperidin-4-yl}-hydroxy-methyl)-2-methoxy-phenyl]ester
10/15/2002US6465489 Such as 1-benzoyl-3-(3,4-dichlorophenyl)-3-(3-(4-(n',n'-dimethylureido)-4 -phenylpiperidin-1-)propyl)piperidine; psychiatric and psychosomatic illnesses, hypertension, central or peripheral pathology
10/15/2002US6465488 Treatment of lipid storage diseases using n-nonyl-1,5-dide-oxy-1,5-imino-d-glucitol; glucosyltransferase inhibitors; tay-sachs, gaucher, krabbe, or fabry disease
10/15/2002US6465487 Inhibition of membrane-associated viral replication
10/15/2002US6465486 Alpha2 adrenoceptor modulators; hypertension, glaucoma, sexual dysfunction, depression, attention deficit hyperactivity disorder, parkinsonism, need for anesthesia, cardiac arrythmia
10/15/2002US6465485 Tetrahydroisoquinoline derivatives as modulators of dopamine D3 receptors
10/15/2002US6465483 Treating or preventing strokes; chronic inflammatory disorders such as bronchial asthma and arthritis; antiproliferative effect; ulcerative colitis and crohn's disease
10/15/2002US6465481 Exhibit electrophysiological activity; may be more potent and produce fewer side effects including lower incidence of proarrhythmias such as torsades de pointes
10/15/2002US6465479 Pyridomorphinans and use thereof
10/15/2002US6465478 Analgesics, antiinflammatories, diuretics, anesthetics, neuroprotective agents, antihypertensive or antianxiety agent, appetite control, hearing regulation
10/15/2002US6465477 Stable pharmaceutical composition
10/15/2002US6465476 Immuno-modulator exhibiting antimicrobial and anti-mycrobacterial activities, method for producing the same and pharmaceutical preparation
10/15/2002US6465474 Treatment of such as osteoarthitis, rheumatoid arthritis, prevention or arrest of tumor growth and metastasis, corneal ulceration, lack of corneal healing, macular degeneration, periodontal disease, gingivitis
10/15/2002US6465473 Method for treatment of reactive arthritis or bursitis
10/15/2002US6465472 Substituted quinazolines and analogs and use thereof
10/15/2002US6465471 Cinnamic acid derivatives
10/15/2002US6465470 R-hydroxynefazodone
10/15/2002US6465469 Depression, migraine headaches, panic disorders, post traumatic stress disorder and sleep disorders; side effect reduction
10/15/2002US6465468 Hydroxamic and carboxylic acid derivatives
10/15/2002US6465466 Protecting dna in initial and/or promoting phase of carcino-genesis; preventing oxidative stress from free radicals due to inflammations, infections, gamma or ultraviolet radiation and vitamin and/or antioxidant deficiency
10/15/2002US6465465 Phosphodiesterase inhibitors
10/15/2002US6465464 Method of using (2-imidazolin-2-ylamino) quinoxalines in treating ocular neural injury
10/15/2002US6465463 Preventing mortality in african american patients haveing hypertension
10/15/2002US6465462 Cognition enhancement for dementing illnesses such as alzheimer's disease
10/15/2002US6465461 5-amino-6-(2,3,5-trichlorophenyl)-1,2,4-triazine; potent, selective anticonvulsant; dihydrofolate reductase inhibitor; analgesics; epilepsy, bipolar disorder, pain
10/15/2002US6465460 Compositions and methods for prevention and treatment of protozoal disease
10/15/2002US6465458 Method of treating or preventing chronic pain with a highly selective norepinephrine reuptake inhibitor
10/15/2002US6465455 Benzamide derivatives for the treatment of diseases mediated by cytokines
10/15/2002US6465454 Combinations of statins and estrogenic agents
10/15/2002US6465453 Azepine derivatives having effects on serotonin related systems
10/15/2002US6465451 Hypolipidemic benzothiazepine compounds
10/15/2002US6465450 Vanadium (IV) complexes containing catecholate ligand and having spermicidal activity
10/15/2002US6465449 Heteroaromatic bicyclic derivatives useful as anticancer agents
10/15/2002US6465448 Treating tumors resistant to temozolomide alone
1 ... 5681 5682 5683 5684 5685 5686 5687 5688 5689 5690 5691 5692 5693 5694 5695 5696 5697 5698 5699 5700 5701 ... 7860